MSI2 and non-small cell lung carcinoma: Furthermore, we have recently shown that MSI2 deficiency leads to higher sensitivity to Epidermal Growth Factor Receptor (EGFR) inhibitors in EGFR mutant NSCLC due to EGFR protein downregulation resulting from MSI2-mediated direct regulation of EGFR mRNA [24].